News & Trends - Biotechnology
Immunotherapy combo doubles survival in hard-to-treat head and neck cancer, challenging standard of care
An ASX-listed biotech has released new survival data demonstrating the potential of its novel immunotherapy combination in first-line recurrent or […]
MoreNews & Trends - Biotechnology
Government backs industry and research partners in regenerative therapy manufacturing
Australia’s push to lead in regenerative therapy manufacturing has taken a major leap forward with the federal government announcing $65 […]
MoreNews & Trends - Biotechnology
Local biotech kicks off phase 3 trial for lung cancer combination therapy
ASX-listed biotech company Immutep has reached a major milestone, announcing that the first patient has been successfully dosed in its […]
MoreNews & Trends - Biotechnology
Aussie biotech announces R&D partnership for first in-human trial in lupus
ASX listed biotech company Noxopharm has engaged a highly-regarded Australian phase 1 unit to deliver the upcoming HERACLES clinical trial. […]
MoreNews & Trends - Biotechnology
AusBiotech and Medicines Australia IWD luncheon: A collective voice for bold action on gender equity
AusBiotech and Medicines Australia are joining forces to host the highly anticipated annual Women in Life Sciences luncheon, set to […]
MoreNews & Trends - Biotechnology
Breaking the silence on lupus: Industry, MPs and patients unite to tackle the critical gaps
Medicines Australia, AstraZeneca, and Noxopharm joined the Parliamentary Friends of Autoimmune Diseases event, spearheaded by the patient advocacy group Dragon […]
MoreNews & Trends - Biotechnology
Aussie biotech leads world-first combination trial in aggressive breast cancer
A world-first clinical trial is set to explore a promising new combination therapy for triple-negative breast cancer, one of the […]
MoreNews & Trends - Biotechnology
Australia’s largest biotech secures first TGA listing for HAE rare disease
The Therapeutic Goods Administration (TGA) has granted approval for the registration of the first treatment targeting factor XIIa, offering new […]
MoreNews & Trends - Biotechnology
Victoria prioritises health technologies and medical research in economic growth statement
AusBiotech and BioMelbourne Network have welcomed the Victorian Government’s release of its Economic Growth Statement, which highlights ‘Health Technologies and […]
MoreNews & Trends - Biotechnology
Aussie biotech secures funding to advance its gene therapy in motor neuron disease
An Australian biotech company has secured one of the largest Series A funding rounds for a biotech start-up in the […]
MoreRecent Posts in Pharma, MedTech & Biotech
Cholesterol drug lowers two major heart disease risks in one stroke
May 12, 2025
in News & Trends - Pharmaceuticals
Boston Scientific’s next-gen cardiac monitor makes clinical debut, intensifying ICM race
May 12, 2025
in News & Trends - MedTech & Diagnostics
World-first trial 3D prints skin directly onto wounds using robotic technology
May 12, 2025
in News & Trends - Biotechnology
TGA clears expanded access to cystic fibrosis therapy following PBAC backing
May 12, 2025
in News & Trends - Pharmaceuticals
Reform blueprint pushes for radical shift amid growing calls for political integrity and transparency
May 9, 2025
in News & Trends - Pharmaceuticals
Australia to launch first guidelines in motor neurone disease
May 9, 2025
in News & Trends - Pharmaceuticals
World-first immunotherapy trial to treat Type 1 diabetes
May 9, 2025
in News & Trends - Pharmaceuticals
Bridging the gap between invention and commercialisation for local medtechs
May 9, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Cholesterol drug lowers two major heart disease risks in one stroke
Lowering cholesterol has long been the cornerstone of reducing cardiovascular risk, yet not all patients respond to existing therapies. Now, […]
MoreNews & Trends - MedTech & Diagnostics
Boston Scientific’s next-gen cardiac monitor makes clinical debut, intensifying ICM race
The first implant of Boston Scientific’s next-generation insertable cardiac monitor (ICM) has been successfully completed by the Director of Cardiac […]
MoreNews & Trends - Biotechnology
World-first trial 3D prints skin directly onto wounds using robotic technology
In a world-first clinical trial, a robot developed by an Australian biotech company is being used to 3D print human […]
MoreNews & Trends - Pharmaceuticals
TGA clears expanded access to cystic fibrosis therapy following PBAC backing
Cystic Fibrosis Australia and Vertex Pharmaceuticals have welcomed the Therapeutic Goods Administration’s (TGA) approval of Trikafta’s (elexacaftor/tezacaftor/ivacaftor and ivacaftor) expanded […]
More